Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Relacorilant |
Synonyms | |
Therapy Description |
Relacorilant (CORT-125134) is a glucocorticoid receptor antagonist, which may decrease tumor growth (PMID: 28967708; Cancer Res July 1 2017 (77) (13 Supplement) 3623). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Relacorilant | CORT-125134|CORT125134 | Relacorilant (CORT-125134) is a glucocorticoid receptor antagonist, which may decrease tumor growth (PMID: 28967708; Cancer Res July 1 2017 (77) (13 Supplement) 3623). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04308590 | Phase III | Relacorilant | Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas (GRADIENT) | Active, not recruiting | USA | ROU | POL | ITA | ISR | ESP | DEU | BGR | AUT | 0 |